Assignee
MEDIMMUNE INC
US·34 granted patents·40 pending applications·2,546 citations·filing 1992–2008
Top patents by PatentIndex Score
74 records- 0199US7083784B2Molecules with extended half-lives, compositions and uses thereofMEDIMMUNE INC·Filed 2001·Granted Aug 1, 2006·704 cites·31 claims
- 0299US5824307AHuman-murine chimeric antibodies against respiratory syncytial virusMEDIMMUNE INC·Filed 1994·Granted Oct 20, 1998·343 cites·30 claims
- 0398US6818216B2Anti-RSV antibodiesMEDIMMUNE INC·Filed 2001·Granted Nov 16, 2004·165 cites·80 claims
- 0497US7229619B1Methods of administering/dosing anti-RSV antibodies for prophylaxis and treatmentMEDIMMUNE INC·Filed 2000·Granted Jun 12, 2007·114 cites·80 claims
- 0597US6656467B2Ultra high affinity neutralizing antibodiesMEDIMMUNE INC·Filed 2001·Granted Dec 2, 2003·96 cites·20 claims
- 0696US7294336B2Stabilized liquid anti-RSV antibody formulationsMEDIMMUNE INC·Filed 2006·Granted Nov 13, 2007·37 cites·60 claims
- 0796US7179900B2Methods of administering/dosing anti-RSV antibodies for prophylaxis and treatmentMEDIMMUNE INC·Filed 2003·Granted Feb 20, 2007·45 cites·80 claims
- 0896US7122194B2Vaccine compositions comprising Streptococcus pneumoniae polypeptides having selected structural motifsMEDIMMUNE INC·Filed 2003·Granted Oct 17, 2006·83 cites·10 claims
- 0996US6855493B2Methods of administering/dosing anti-RSV antibodies for prophylaxis and treatmentMEDIMMUNE INC·Filed 2001·Granted Feb 15, 2005·72 cites·73 claims
- 1096US6689369B2Immunogenic pneumococcal protein and vaccine compositions thereofMEDIMMUNE INC·Filed 2001·Granted Feb 10, 2004·71 cites·19 claims
- 1195US7323172B2Methods of administering/dosing anti-RSV antibodies for prophylaxis and treatmentMEDIMMUNE INC·Filed 2004·Granted Jan 29, 2008·48 cites·12 claims
- 1295US7297337B2EphA2 T-cell epitopes and uses thereforMEDIMMUNE INC·Filed 2005·Granted Nov 20, 2007·26 cites·45 claims
- 1395US7132100B2Stabilized liquid anti-RSV antibody formulationsMEDIMMUNE INC·Filed 2003·Granted Nov 7, 2006·49 cites·89 claims
- 1494US7425618B2Stabilized anti-respiratory syncytial virus (RSV) antibody formulationsMEDIMMUNE INC·Filed 2003·Granted Sep 16, 2008·55 cites·55 claims
- 1594US7354584B2Recombinant IL-9 antibodiesMEDIMMUNE INC·Filed 2004·Granted Apr 8, 2008·50 cites·9 claims
- 1694US6582706B1Vaccine compositions comprising Streptococcus pneumoniae polypeptides having selected structural MOTIFSMEDIMMUNE INC·Filed 1999·Granted Jun 24, 2003·106 cites·11 claims
- 1793US6833356B1Pneumococcal protein homologs and fragments for vaccinesMEDIMMUNE INC·Filed 2000·Granted Dec 21, 2004·42 cites·8 claims
- 1893US6565849B2Methods of enhancing activity of vaccines and vaccine compositionsMEDIMMUNE INC·Filed 2001·Granted May 20, 2003·45 cites·19 claims
- 1987US7351533B2In vitro method for disassmbly/reassembly of papillomavirus virus-like particles (VLPs). Homogeneous VLP and cavsomere compositions produced by said methods: use thereof as vehicle for improved purification, and delivery of active agentsMEDIMMUNE INC·Filed 2004·Granted Apr 1, 2008·27 cites·15 claims
- 2085US7435421B2Derivatives of choline binding proteins for vaccinesMEDIMMUNE INC·Filed 2005·Granted Oct 14, 2008·6 cites·6 claims
- 2184US7371383B2Recombinant anti-interleukin-9 antibodiesMEDIMMUNE INC·Filed 2003·Granted May 13, 2008·21 cites·44 claims
- 2284US6416945B1Vitro method for disassembly/reassembly of papillomavirus virus-like particles (VLPS)MEDIMMUNE INC·Filed 1999·Granted Jul 9, 2002·57 cites·9 claims
- 2383US5583038ABacterial expression vectors containing DNA encoding secretion signals of lipoproteinsMEDIMMUNE INC·Filed 1992·Granted Dec 10, 1996·98 cites·31 claims
- 2482US6962701B2Methods of priming the immunogenic activity of vaccines useful for eliciting a protective immune responseMEDIMMUNE INC·Filed 2003·Granted Nov 8, 2005·8 cites·13 claims
- 2582US6908613B2Chimeric human papillomavirus (HPV) L1 molecules and uses thereforMEDIMMUNE INC·Filed 2001·Granted Jun 21, 2005·21 cites·5 claims
- 2681US6887480B1Streptococcus pneumoniae proteins and vaccinesMEDIMMUNE INC·Filed 2000·Granted May 3, 2005·10 cites·9 claims
- 2780US6863893B2Derivatives of choline binding proteins for vaccinesMEDIMMUNE INC·Filed 2002·Granted Mar 8, 2005·10 cites·14 claims
- 2878US6737063B2FimH adhesin proteins and methods of useMEDIMMUNE INC·Filed 2001·Granted May 18, 2004·23 cites·4 claims
- 2974US6503511B1Derivatives of choline binding proteins for vaccinesMEDIMMUNE INC·Filed 1999·Granted Jan 7, 2003·27 cites·13 claims
- 3070US6261765B1In vitro method for disassembly/reassembly of papillomavirus virus-like particles (VLPs)MEDIMMUNE INC·Filed 1999·Granted Jul 17, 2001·23 cites·18 claims
- 3169US6500434B1Chaperone and adhesin proteins; vaccines, diagnostics and method for treating infectionsMEDIMMUNE INC·Filed 1999·Granted Dec 31, 2002·27 cites·37 claims
- 3267US7309490B2Methods of priming the immunogenic activity of vaccines useful for eliciting a protective immune responseMEDIMMUNE INC·Filed 2005·Granted Dec 18, 2007·0 cites·11 claims
- 3365US2005158342A1Multi plasmid system for the production of influenza virusMEDIMMUNE INC·Filed 2004·Application pending·0 cites
- 3464US2008096263A1Recombinant Parainfluenza Virus Expression Systems And Vaccines Comprising Heterologous Antigens Derived From Respiratory Syncytial VirusMEDIMMUNE INC·Filed 2007·Application pending·0 cites
- 3564US2009053238A1Stabilized High Concentration Anti-Integrin alphavbeta3 Antibody FormulationsMEDIMMUNE INC·Filed 2006·Application pending·0 cites
- 3663US2007025990A1Methods of administering/dosing CD2 antagonists for the prevention and treatment of autoimmune disorders or inflammatory disordersMEDIMMUNE INC·Filed 2006·Application pending·0 cites
- 3763US2005147593A1EphA2, EphA4 and LMW-PTP and methods of treatment of hyperproliferative cell disordersMEDIMMUNE INC·Filed 2004·Application pending·0 cites
- 3862US2005042664A1Humanization of antibodiesMEDIMMUNE INC·Filed 2004·Application pending·0 cites
- 3962US2008071063A1Protein FormulationsMEDIMMUNE INC·Filed 2007·Application pending·0 cites
- 4062US2007202122A1Non-splicing variants of gp350/220MEDIMMUNE INC·Filed 2006·Application pending·0 cites
- 4161US2009047277A1Recombinant il-9 antibodies and uses thereofMEDIMMUNE INC·Filed 2007·Application pending·0 cites
- 4260US5736367AVectors and prokaryotes which autocatalytically delete antibiotic resistanceMEDIMMUNE INC·Filed 1995·Granted Apr 7, 1998·27 cites·14 claims
- 4360US2004208870A1Stabilized high concentration anti-integrin alphanubeta3 antibody formulationsMEDIMMUNE INC·Filed 2004·Application pending·0 cites
- 4460US2009175883A1Stabilized anti-respiratory syncytial virus (RSV) antibody formulationsMEDIMMUNE INC·Filed 2008·Application pending·0 cites
- 4559US2010260749A1Modulators of EphA2 and Ephrin-A1 for the treatment of fibrosis-related diseaseMEDIMMUNE INC·Filed 2008·Application pending·0 cites
- 4658US2007092523A1Combination Therapy Of Respiratory Diseases Using AntibodiesMEDIMMUNE INC·Filed 2006·Application pending·0 cites
- 4757US2007166314A1EpA2 monoclonal antibodies and methods of use thereofMEDIMMUNE INC·Filed 2007·Application pending·0 cites
- 4856US2010278813A1Methods of treating and preventing RSV, hMPV, and PIV using anti-RSV, anti-hMPV, and anti-PIV antibodiesMEDIMMUNE INC·Filed 2007·Application pending·0 cites
- 4956US2006115485A1Methods of preventing and treating RSV infections and related conditionsMEDIMMUNE INC·Filed 2005·Application pending·0 cites
- 5055US2004208869A1Uses of anti-integrin alphanubeta3 antibody formulationsMEDIMMUNE INC·Filed 2004·Application pending·0 cites
Showing the top 50 of 74 patent records by PatentIndex Score.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →